Owner Scorecard


← All companies ← HOG Manual HOMB → ← HAE Medical Devices & Equipment HTFL →

HOLX, Hologic

Medical Devices & Equipment capital-intensive CyclicalSerial acquirer

We are a developer, manufacturer and supplier of premium diagnostics products, medical imaging systems, and surgical products focused on women's health and well-being through early detection and treatment.

We sell and service our products through a combination of direct sales and service personnel and a network of independent distributors and sales representatives.

Our primary Diagnostics products include our molecular diagnostic assays, which run on our advanced instrumentation systems (Panther and Panther Fusion), our cytology systems, including the ThinPrep System, and the Genius Digital Diagnostics System, and the Rapid fFN Test.

Latest annual: FY2025 10-K
HOLX · Hologic
I

The business

What it sells, where the money comes from, the kind of company it is.

Revenue · FY2025
$4.1B
+1.7% YoY · 2% 5-yr CAGR
Vital signs · TTM, with 5-yr average
Revenue $4.1B 5-yr avg $4.5B
Gross margin 61% 5-yr avg 65%
Operating margin 17.5% 5-yr avg 26.7%
ROIC 11% 5-yr avg 18%
Owner-earnings margin 25% 5-yr avg 32%
Free cash flow margin 25% 5-yr avg 32%

The business in brief

read the 10-K →

What this business is and what moves its needle, from its own SEC filings.

What it is
Revenue is led by Diagnostics (45%) and Breast Health (36%), with 2 more segments behind.
Situation
Cyclical. Margins collapse and recover repeatedly across the record; a single year, good or bad, misstates the through-cycle earning power. Serial acquirer. Goodwill and acquired intangibles are 47% of assets, with meaningful acquisition spending in 8 of the record's 10 years; much of what this business is was bought, at prices the record carries.
What moves the needle
Gross margin has run about 60% and operating margin about 21% through the cycle, a wide spread between price and the cost of what it sells — whether that advantage is durable pricing power or a margin that can erode is the question the record is for. The margin is cyclical, swinging between −7.4% and 45% over the years, so the through-cycle figure carries more than any single year — and the balance sheet at the trough more than the peak. Read this kind of business on the installed base and what follows it. On its own account, the filing leans hardest on pricing power & competition, set against the numbers in what the filing emphasizes, below.
Is it a good business?
Return on capital has sat near the cost of capital (median 13%). By owner earnings: roughly 24% of revenue reaches owners as cash, consistently. The cycle and the balance sheet decide this one; the worst year tells more than the median, and the rest is in the 10-K.

Every line is arithmetic on the company's filings, shown in full in the sections below.

Where the money comes from

read the 10-K →

The biggest segment, Diagnostics, is also where the profit is made: 45% of revenue and 48% of the profitable segments' operating profit. Skeletal Health ran a $4M operating loss.

Revenue by reportable segment, FY2025
Operating profit profitable segments only
  • Diagnostics45%$1.8B48% of profit
  • Breast Health36%$1.5B35% of profit
  • GYN Surgical17%$680M16% of profit
  • Skeletal Health3%$109Mloss of $4M
By geographyUnited States74%Europe14%Asia Pacific6%Rest of World5%

From the segment footnote of the company's own 10-K. Shares are of total revenue; the profit bar shows each segment's share of the profitable segments' operating profit (a loss-making segment carries its loss in dollars in the legend, not a share of the bar), before unallocated corporate costs.

II

The record

Ten years of arithmetic, read across the cycle.

The record, 2016–2025

realized figures from each filing · older years to the left
2016’162017’172018’182019’192020’202021’212022’222023’232024’242025’25TTMTTMDec 2025
Income statement
$2.8B$3.1B$3.2B$3.4B$3.8B$5.6B$4.9B$4.0B$4.0B$4.1B$4.1BRevenueRevenue
$1.2B$2.2B$3.8B$3.0B$2.5BGross profitGross prof.
35%59%67%62%61%Gross marginGross mgn
24%28%28%27%22%18%21%25%25%26%26%SG&A / revenueSG&A/rev
8%8%7%7%6%5%6%7%7%6%6%R&D / revenueR&D/rev
$549M$1.4B($238M)($124M)$1.1B$2.5B$1.6B$668M$883M$714M$722MOperating incomeOp. inc.
19.4%44.8%−7.4%−3.7%29.3%44.0%33.7%16.6%21.9%17.4%17.5%Operating marginOp. mgn
$415M$1.2B($419M)($258M)$1.0B$2.4B$1.6B$676M$865M$681MPretax incomePretax
$331M$756M($111M)($204M)$1.1B$1.9B$1.3B$456M$790M$566M$544MNet incomeNet inc.
20%39%21%18%33%9%17%18%Effective tax rateTax rate
Cash flow & returns
$798M$8M$733M$650M$897M$2.3B$2.1B$1.1B$1.3B$1.1B$1.1BOperating cash flowOp. cash
$465M$449M$480M$463M$376M$407M$430M$323M$309M$300M$295MDepreciation & amortizationD&A
($63M)($1.3B)$299M$328M($678M)($13M)$327M$192M$104M$107M$177MWorking capital & otherWC & other
$47M$58M$58M$57M$98M$118M$71M$92M$72M$59M$57MCapexCapex
1.7%1.9%1.8%1.7%2.6%2.1%1.5%2.3%1.8%1.4%1.4%Capex / revenueCapex/rev
$751M($50M)$675M$593M$798M$2.2B$2.1B$959M$1.2B$998M$1.0BOwner earningsOwner earn.
26.5%−1.6%21.0%17.6%21.1%39.3%42.3%23.8%30.1%24.3%25.2%Owner earnings marginOE mgn
$751M($50M)$675M$593M$798M$2.2B$2.1B$959M$1.2B$998M$1.0BFree cash flowFCF
26.5%−1.6%21.0%17.6%21.1%39.3%42.3%23.8%30.1%24.3%25.2%Free cash flow marginFCF mgn
$0$1.6B$77M$111M$119M$1.2B$159M$5M$297M$322M$322MAcquisitionsAcquis.
$250M$200M$276M$200M$654M$410M$542M$475M$835M$753MBuybacksBuybacks
($68M)$286M($195M)($281M)($142M)($1.3B)($206M)($152M)($781M)($483M)Investing cash flowInv. cash
($671M)($309M)($405M)($432M)($660M)($530M)($756M)($483M)($1.1B)($777M)Financing cash flowFin. cash
($2M)$7M($7M)($2M)$4M($2M)$6M$300K$9M$2MExchange-rate effectFX
$57M($8M)$126M($65M)$99M$469M$1.2B$416M($596M)($201M)Change in cashΔ cash
9%15%-4%-2%22%32%25%9%15%11%11%ROICROIC
15%27%-5%-10%41%44%27%9%15%11%10%Return on equityROE
15%27%−5%−10%41%44%27%9%15%11%10%Retained to equityRetained/eq
Balance sheet
$548M$541M$667M$602M$701M$1.2B$2.3B$2.7B$2.3B$2.2B$2.4BCash & investmentsCash+inv
$447M$534M$579M$649M$1.0B$943M$618M$626M$600M$601M$584MReceivablesReceiv.
$275M$332M$384M$445M$395M$501M$624M$618M$680M$679M$689MInventoryInvent.
$157M$167M$192M$187M$179M$216M$198M$175M$204M$193M$201MAccounts payablePayables
$565M$699M$771M$907M$1.2B$1.2B$1.0B$1.1B$1.1B$1.1B$1.1BOperating working capitalOper. WC
$1.3B$1.5B$1.7B$1.8B$2.2B$3.2B$3.9B$4.2B$3.8B$3.7B$3.8BCurrent assetsCur. assets
$902M$1.9B$1.4B$1.1B$1.2B$1.3B$938M$1.2B$1.0B$977M$951MCurrent liabilitiesCur. liab.
1.5×0.8×1.2×1.7×1.8×2.4×4.1×3.5×3.7×3.8×4.0×Current ratioCurr. ratio
$473M$473M$478M$471M$492M$565M$482M$517M$538M$560MNet PP&ENet PP&E
$2.8B$3.2B$2.5B$2.6B$2.7B$3.3B$3.2B$3.3B$3.4B$3.6B$3.6BGoodwillGoodwill
$7.3B$8.0B$7.2B$6.4B$7.2B$8.9B$9.1B$9.1B$9.2B$9.0B$9.2BTotal assetsAssets
$3.4B$3.4B$3.3B$3.1B$3.1B$3.1B$2.9B$2.8B$2.5B$2.5B$2.5BTotal debtDebt
$2.9B$2.8B$2.7B$2.5B$2.4B$1.9B$511M$113M$214M$316M$154MNet debt / (cash)Net debt
3.5×8.9×-1.6×-0.9×9.5×26.5×17.2×6.0×7.2×6.1×6.3×Interest coverageInt. cov.
$0$2M$0Noncontrolling interestsNCI
$2.1B$2.8B$2.4B$2.1B$2.7B$4.2B$4.9B$5.0B$5.1B$5.0B$5.2BShareholders’ equityEquity
2.3%2.2%2.0%1.8%2.2%1.2%1.4%2.0%2.0%2.1%2.0%Stock comp / revenueSBC/rev
Per share
286M286M275M269M265M260M254M249M238M228M226MShares out (diluted)Shares
$9.90$10.71$11.70$12.50$14.27$21.69$19.16$16.20$16.97$18.02$18.27Revenue / shareRev/sh
$1.16$2.64$-0.40$-0.76$4.21$7.21$5.13$1.83$3.32$2.49$2.41EPS (diluted)EPS
$2.62$-0.17$2.45$2.20$3.02$8.52$8.10$3.86$5.11$4.39$4.61Owner earnings / shareOE/sh
$2.62$-0.17$2.45$2.20$3.02$8.52$8.10$3.86$5.11$4.39$4.61Free cash flow / shareFCF/sh
$0.17$0.20$0.21$0.21$0.37$0.46$0.28$0.37$0.30$0.26$0.25Cap. spending / shareCapex/sh
$7.49$9.75$8.83$7.85$10.22$16.24$19.21$20.16$21.60$22.18$23.22Book value / shareBVPS
Per-share growththe realized rate an owner's share compounded
9-yr5-yr
Revenue / share+6.9%/yr+4.8%/yr
Owner earnings / share+5.9%/yr+7.8%/yr
EPS+8.9%/yr−10.0%/yr
Capital spending / share+5.1%/yr−7.0%/yr
Book value / share+12.8%/yr+16.8%/yr

The year, in the company's words

the filing →

Verbatim from the 10-K's management discussion. Each sentence is shown only because its subject, direction, and stated figures check out against the filed numbers on this page. The words are the company's; the arithmetic is the record's.

  • Diagnostics+2.5%
    “Diagnostics product revenues increased 2.1% in fiscal 2025 compared to fiscal 2024 primarily due to an increase in our Molecular Diagnostics business and to a lesser extent an increase in our Cytology business.”
    ✓ figure matches the filed record
  • Skeletal Health+30.1%
    “Skeletal Health product revenues increased 31.9% in fiscal 2025 compared to fiscal 2024 primarily due to an increase in sales volume of our Horizon DXA systems from pent up demand as the temporary stop-ship implemented during the third quarter of fiscal 2024 due to a non-conformance matter pertaining to electromagnetic compatibility requirements was fully resolved for all Horizon DXA models in the third quarter of the current fiscal year.”
    ✓ direction matches the filed record

Where the cash went

ReinvestBuybacksDividendsAcquisitionsRetainedBeyond op. cash

Each year's outlays against its operating cash: the mix, and how it drifts. The hatched cap is spending beyond that year's operating cash — financed from the balance sheet or borrowing, not operations.

FY2016FY2025

Net income is the accountant's number; owner earnings is the cash an owner could take out. The walk between them, off the cash-flow statement, and whether the gap is widening or holding.

In fiscal 2025 the business turned $566M of profit into $998M of owner earnings: more cash than the profit line showed, after the non-cash charges and the capital it put back in.

Reported net income$566M
Owner earnings$998M · 24% of revenue
FY2025FY2024FY2023FY2022FY2021
Reported net income$566M$790M$456M$1.3B$1.9B
Depreciation & amortizationnon-cash charge added back+$300M+$309M+$323M+$430M+$407M
Stock-based compensationreal costnon-cash, but a real cost+$84M+$82M+$80M+$67M+$65M
Working capital & othertiming of cash in and out, other non-cash items+$107M+$104M+$192M+$327M−$13M
Cash from operations$1.1B$1.3B$1.1B$2.1B$2.3B
Capital expenditurecash put back in to keep running and to grow−$59M−$72M−$92M−$71M−$118M
Owner earnings$998M$1.2B$959M$2.1B$2.2B
Owner-earnings marginowner earnings ÷ revenue24%30%24%42%39%

Owner earnings is the cash an owner could pull out without starving the business: operating cash less the capital it must spend to hold its position . The cash-flow statement also adds stock comp back as non-cash, but it is a real cost paid in shares; counted as the expense it is (less $84M), owner earnings is nearer $914M.

Maintenance capex is estimated as depreciation where a growing business invests above it; free cash flow is the figure the scorecard's free-cash margin reads.

III

Quality & stewardship

Returns, the balance sheet, capital allocation, and pay.

Owner’s Scorecard

FY2025 10-K · source on SEC EDGAR →

Will it survive?

  • Comfortable
    Operating income $714M ÷ interest expense $117M
    What this means

    Operating profit covers interest with the kind of margin Graham wanted for a defensive holding. Necessary, not sufficient, it says solvent, not cheap.

  • How heavy is the debt, net of cash? $316M · 0.4× operating profit
    Modest net debt
    Cash $2.0B + ST investments $243M − debt $2.5B
    What this means

    Netting $2.2B of cash and short-term investments against $2.5B of debt leaves $316M owed, about 0.4× a year's operating profit (3.5× on the gross debt, before the cash). Net debt is the leverage figure that matters: the cash is already set against the debt. Strategic or illiquid investments aren't counted here.

  • Not enough data
    What this means

    The filing data didn't include the inputs for this check.

Is it a good business?

  • Solid through the cycle
    10-yr median, range -4%–32%; 11% latest = NOPAT $593M ÷ invested capital $5.6B
    Industry peers: median 10%
    What this means

    The rate the business earns on the money tied up in it, Buffett's north star, because over time a stock tracks the ROIC beneath it. Above ~15% sustained hints at a moat; a return below the cost of capital (~8%) erodes value as a business grows rather than building it — the test Buffett weighs most. The headline is the median of the last 10 years (it ran 11% most recently), so one peak or trough year doesn't set the verdict. Asset-light businesses (R&D expensed, little capital) read artificially high, pair this with Owner Earnings.

  • High through the cycle
    10-yr median margin, range -2%–42%; latest $998M = operating cash $1.1B − maintenance capex $59M
    Industry peers: median 17%
    What this means

    What an owner could take out without starving the business: operating cash less the maintenance capital it must spend to hold its position — Buffett's owner earnings. That's 24% of revenue this year, a 24% median across 10 years. Treating stock comp as the real expense it is (less $84M of SBC) leaves $914M.

  • Cash-backed
    Cash from ops $1.1B ÷ net income $566M
    What this means

    How much of reported profit showed up as operating cash. Above 1× is reassuring; well below suggests earnings lean on accruals. One year is noisy, growth and working-capital swings distort it, and this is operating cash, not free cash. Watch the multi-year trend.

How is the cash used?

  • Returns about half
    Dividends + buybacks $753M ÷ Owner Earnings $998M — this fiscal year
    What this means

    Of $998M Owner Earnings, $753M (75%) went back to shareholders, $0 dividends, $753M buybacks. Net of $84M stock comp, the real buyback was about $669M. Returning most of it is the mark of a mature business with little left to reinvest at a high return; reinvesting most could mean a long runway, or empire-building. The split doesn't say which; the return earned on it (see ROIC) does. This year's proportion is 75%; across the record (2016–2025) it is 45%, the capital-allocation section below.

  • Investing or harvesting? 0.20×
    Harvesting
    Capex $59M ÷ depreciation & amortization as filed $300M
    What this means

    Descriptive, not a grade. Above ~1× means investing faster than assets wear out (growth, or, sustained for years, today's earnings carrying less depreciation than tomorrow's will). Below means spending less than it's wearing out (efficiency, or a melting asset base). The ratio won't tell you which; the filings will.

The promise and the pay packet

  • Modest selling cost
    Selling and marketing $621M ÷ revenue $4.1B
    What this means

    Sales and marketing as a share of revenue, kept apart from administrative overhead because it answers a different question: how much a business must spend to win the next customer. A company whose product pulls customers in spends little here and keeps the difference; one that must buy its growth is running to stand still, and the spending has to keep rising for revenue to keep rising. Read it beside the growth rate, not alone.

  • Is the buyback buying ownership, or mopping up? 2.1%
    The count is genuinely shrinking
    Stock compensation $84M (fiscal 2025), 2.1% of revenue · repurchases $753M · diluted shares -10.3% since 2022
    What this means

    Stock handed to employees is a real cost paid in the owner's own currency: it is charged against profit, but the shares it creates are permanent. Many companies repurchase stock at the same time, which looks like a return of capital and often is not — if the count barely moves, the cash merely cancelled the pay packet and bought the owner nothing. The three states worth telling apart are a count genuinely shrinking, a count standing still despite large repurchases, and a count rising because the issuance was never offset at all.

Graham’s defensive tests · 4 of 5 met

Graham’s numerical criteria for the defensive investor (The Intelligent Investor, ch. 14), run on the filings. A floor of safety, not a buy signal; many fine modern businesses fail his strictest liquidity rules by design.

  • Adequate size Pass
    Revenue ≥ $2B · $4.1B
    What this means

    Big enough to weather a storm. Graham's 1972 floor was ~$100M of sales (≈ $700M today); we use a $2B revenue line as a conservative modern stand-in.

  • Strong liquidity Pass
    Current ratio ≥ 2× · 3.75×
    What this means

    Current assets at least twice current liabilities, near-term bills covered without touching the business. Strict by design: many cash-rich modern firms run leaner and miss it, holding their cushion in longer-dated securities.

  • Conservative debt Pass
    Debt ≤ working capital · $2.5B vs $2.7B WC
    What this means

    Graham's rule that borrowings not exceed net current assets. Capital-heavy and buyback-heavy firms routinely fail it, read it next to interest coverage, not alone.

  • Earnings stability Miss
    A profit every year (10-yr record) · 2 loss years
    What this means

    Graham wanted earnings in each of the past ten years, the stability a defensive owner leans on.

  • Dividend record
    Uninterrupted dividends · no dividend line tagged in the data
    What this means

    An unbroken dividend was Graham's mark of durability. This record carries no dividends-paid line in any year — common for partnerships, whose distributions file under tags the chain doesn't read — so the criterion is withheld rather than judged on silence.

  • Earnings growth Pass
    Earnings +33% over the record · +86%
    What this means

    At least a third more earnings than a decade ago, averaging three years at each end. Net income (not per-share), so stock splits don't distort it, buybacks and dilution show up in the share-count line instead.

  • Moderate price
    P/E ≤ 15 and P/E × P/B ≤ 22.5 · decided by the price
    What this means

    Graham's valuation gate, the wall he kept between a sound business and a sound investment. Three-year average earnings are $2.70/share (latest year $2.53), the averaged base the calculator's gate runs on, and book value is $22.61/share. Enter a price in “What the price implies” just below for the P/E, P/B, and whether it clears. But this is the rule Buffett outgrew: there's no hard P/E law, and a wonderful business can deserve a far richer multiple if the thesis holds, treat it as the bargain-hunter's floor, not a verdict on the price.

Durability & moat, 2016–2025

Whether the record’s returns held, and what the capital reinvested earned.

  • Profitable years 8 of 10
    What this means

    Lost money in 2 year(s), look at what happened there before trusting the average.

  • Return on capital ≥ 15% 4 of 10 yrs
    What this means

    A moat shows up as a high return on invested capital that holds year after year, not one good vintage.

  • Operating margin 19% → 19% (3-yr avg ends)
    What this means

    Through the cycle the operating margin held roughly steady — about 19% early, 19% lately, median 19%.

  • Reinvestment, incremental ROIC returns capital
    What this means

    The capital base barely grew: this business returns cash through dividends and buybacks rather than reinvesting. Judge it on the cash returned, not on compounding.

  • Owner earnings growth +14%/yr
    What this means

    Owner earnings grew about 14% a year over the record.

  • Worst year 2018 · −7.4% op. margin
    What this means

    Operations went underwater in 2018, understand why before trusting the good years.

  • Share count −2.5%/yr
    What this means

    The share count is shrinking, buybacks are quietly growing your slice of the business.

All figures as filed; the source filing is linked above.

Current Position

as of the latest quarter, Dec 27, 2025

Can the business pay what it owes this year, off the freshest balance sheet: the quality of the assets, the debt actually coming due, and what a low ratio means here.

Current assets$3.8B
  • Cash & short-term investments$2.4B
  • Receivables$584M
  • Inventory$689M
  • Other current assets$206M
Current liabilities$951M
  • Debt due within a year$6M
  • Accounts payable$201M
  • Other current liabilities$744M
Current ratio4.04×all current assets ÷ what's due · Graham looked for 2×
Quick ratio3.32×stricter: inventory excluded
Cash ratio2.49×strictest: cash alone against what's due
Working capital$2.9Bthe cushion left after near-term bills
Debt due this year vs. cash$6M due · $2.4B cash covered by cash on hand, no refinancing forced · both figures from the Dec 27, 2025 balance sheet
Revenue, latest quarter vs. a year ago+2.5%the freshest read on whether the business is still growing
Current ratio, recent quarters4.0× → 4.0×
Deeper floors
Tangible book value$1.1Bequity stripped of goodwill & intangibles
Debt incl. operating leases$2.6B$106M of it operating leases
Deferred revenue$183Mcustomer cash collected before delivery; operating float

From the company's latest filing.

How the cash was used, 2016–2025

Over the record, the business generated $10.9B of operating cash; how management split it reads as a balanced allocator, splitting cash between the business, owners, and the balance sheet.

  • Reinvested$731M · 7%
  • Buybacks$4.6B · 42%
  • Retained (debt / cash)$5.6B · 51%
  • Returned to owners$4.6B

    45% of the owner earnings the business produced over the span, $0 as dividends and $4.6B as buybacks.

  • Average price paid for buybacks$109.82

    Across the years where the filing reports a share count, 33M shares were bought for $3.6B, about $109.82 each. Year to year the price paid ranged from $41.69 (2019) to $313.71 (2025); its heaviest year, 2024, paid $198.83 ($835M).

  • Net change in share count−21.1%

    The diluted count fell from 286M to 226M, so the buybacks outran the stock issued to staff.

  • Dividend record

    No dividend line was reported in the filing data over the span; the record here neither confirms nor rules out a payout.

  • Return on what it retained26%

    Of the earnings it kept rather than paid out ($2.3B over the span), annual owner earnings (first three years vs last three) grew $598M, so each retained $1 added about 0.26 of yearly owner earnings. Buffett's test, run on owner earnings instead of market value.

Buybacks are gross of stock issued to staff; the share-count line above is the net of that, the figure that decides whether owners gained. The average price paid blends a year of purchases (and any accelerated repurchase), so it is close, not exact. The record of where the cash went and on what terms.

Acquisitions & goodwill

from the balance sheet & the 10-year cash-flow record

Goodwill grows only when a company acquires and falls only when it concedes it overpaid. The size of that bet, the cash put into buying rather than building, and how much has already been written off.

Goodwill & intangibles$4.2B47% of all assets; the premium carried on the balance sheet for businesses acquired
Against book equity72%goodwill is this share of book equity; the rest is the company’s own retained and paid-in capital
Cash spent acquiring$10.5Bover 19 years since fiscal 2007 buying other businesses, against $731M of capital spent building over the 10-year record

$686M written down across 1 year (2018): goodwill the company has already conceded it overpaid for, charged against earnings. That is roughly 18% of the cash it put into acquisitions over the span. A write-down costs no cash (the cash went out when the deal was signed), but it is management marking its own past judgment to market.

Beside that spending sits $1.5B of cumulative amortization of acquired intangibles charged against earnings since fiscal 2007 — the purchase price of past deals, expensed over time.

Goodwill, acquired intangibles and equity from the latest balance sheet; acquisition spend and amortization summed across the company's full tagged history, write-downs across the 10-year record, from the company's own filings.

Management, ownership & pay

read the proxy →

From the proxy: how much of the business the people running it own, and how they are paid, beside what the business earned for its owners in the same years.

Fiscal yearChief executivePay, as filed“Actually paid”Owner earnings
2021Stephen P. MacMillan$14.7M$32.7M$2.2B
2022Stephen P. MacMillan$14.3M$8.7M$2.1B
2023Stephen P. MacMillan$15.6M$21.1M$959M
2024Stephen P. MacMillan$15.8M$21.3M$1.2B

Both pay figures are the company’s own, from the pay-versus-performance table its proxy statement files. “As filed” is the Summary Compensation Table total: salary, bonus, and equity awards at their value on the day of grant. “Actually paid” is the SEC’s prescribed recalculation, which re-marks those equity awards to what they became as they vested; it can swing far above or below the filed figure in either direction, and negative years occur. Owner earnings are the whole business's, from the record above, for the same fiscal years.

  • Insider ownership1.9%

    The stake all directors and executive officers hold together, per the 2025 proxy: skin in the game, the first thing Munger reads.

  • Stock-based compensation$84M

    The slice of the business handed to employees in shares in fiscal 2025, 2.1% of revenue, equal to 11.8% of operating profit. Buffett's oldest accounting fight: this is compensation, compensation is an expense, real whether or not the headline earnings admit it. One trap: the cash-flow statement adds SBC back, so the operating cash, and the owner earnings drawn from it, are flattered by exactly this amount; counted as the cost it is, what an owner keeps is lower.

What an owner would ask, FY2025

read the 10-K →
  • Which reported numbers are a judgment call?
    Management names Revenue recognition, Income taxes, Inventory, Acquisitions as critical estimates

    each rests partly on management's judgment; the filing's note sets out the assumptionsverify →

The questions the record and the charts do not answer on their own; each carries the figure and the place to look.

Peers, Medical Devices & Equipment

The same industry, side by side on owner economics. Each column names the period it is read over, and a median resting on fewer than three years carries that count beside it; the group median at the foot is the line to read each figure against.

CompanyRevenuelatest FY, USDGross marginmedian over the recordOp. marginmedian over the recordROICmedian over the recordOwner earn. marginmedian over the record
RMDResMed Inc.$5.7B57%27.7%19%19%
DXCMDexCom Inc.$4.7B65%12.1%10%17%
HOLXHologic$4.1B60%4y20.6%13%24%
ALGNAlign Technology$4.0B72%19.9%23%22%
XRAYDENTSPLY SIRONA Inc.$3.7B53%-6.8%-6%10%
MMEDMiniMed Group Inc.$3.1B56%-5.4%-3%-4%
GMEDGlobus Medical$2.9B75%19.9%11%17%
NVSTEnvista Holdings$2.7B56%10.3%4%12%
Group median59%16.0%10%17%
IV

The price

What a price has to assume.

What the price implies

reverse-DCF

Type today's close and see the owner-earnings growth you'd have to believe to justify it, beside what Hologic has delivered.

$

Through the cycle, Hologic earns about $987M on its 24.1% median owner-earnings margin. This year’s 24.3% margin runs in line with that. Normalize, below, values the price on that through-cycle figure rather than the latest year.

Base

The assumptions

9.0% = the 4.71% 10-year Treasury (Aug 18, 2026) + 4.29 points of equity premium. The rate you require is yours to set.

Enter a price above to run it.

Implied by the price
Owner-earnings growth · ’21→’25−15%/yr
Owner-earnings growth · ’16→’25+14%/yr
Owner-earnings yield
P/E (3-yr earnings ’23–’25)
P/B
Graham’s price gate

Graham capped the multiple at 15×; Buffett and Munger let that rule go: a wonderful business can deserve 50× if the thesis holds. The gate marks the bargain-hunter's floor.

Against a high-grade bond: Graham’s yardstick bond yield%

Prefilled with the 10-year Treasury (4.71%, as of Aug 18, 2026). Edit it for today’s exact figure, or a AAA corporate yield.

Graham measured a stock against the bond you could own instead, the heart of his margin of safety. Enter a price above to weigh the owner-earnings yield against this bond.

Owner earnings $1.0B on 223M shares outstanding, per the 10-Q cover, as of 2026-01-23; net debt $154M. The base is the latest year by default; Normalize values it on the through-cycle median owner-earnings margin (to avoid paying on a peak year). Net of stock comp treats option pay as the expense it is. The dials set the multiple a growth belief justifies; the price, and every dollar on this page, is yours.

Cite: Owner Scorecard, "Hologic (HOLX), the owner's record," https://ownerscorecard.com/c/HOLX, data as of 2026-08-17.

Manual order: ← HOG its page in the Manual HOMB →

Industry order: ← HAE the Medical Devices & Equipment chapter HTFL →